American journal of preventive medicine · 2026
Telehealth and Hybrid Service Use for Major Depression and Substance Use Disorders Among U.S. Adults, 2022-2023.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Wenhua, Liu Yifan, Yoon Anderson Sungmin
Аннотация
INTRODUCTION: This study examined patterns of telehealth and hybrid service use (telehealth combined with outpatient or inpatient care) for major depressive episodes and substance use disorders among U.S. adults.
METHODS: Pooled data from the 2022 and 2023 National Survey on Drug Use and Health (N=92,233) were analyzed to examine trends and patterns in overall telehealth use and hybrid service use among adults with past-year major depressive episodes and those with past-year substance use disorders. Bivariate analyses and survey-weighted multivariable logistic regression were conducted between December 2024 and May 2025.
RESULTS: Among adults with past-year major depressive episodes, telehealth use remained stable at around 44% from 2022 to 2023, whereas outpatient care remained the most common treatment modality and increased from 46.1% to 50.0% (OR=1.16, p<0.05). Among adults with past-year substance use disorders, telehealth use increased nonsignificantly from 5.4% in 2022 to 6.2% in 2023. For major depressive episodes, telehealth use was higher among females than among males (AOR=1.41, p<0.001) and among those with Medicaid (AOR=1.90, p<0.001) or private insurance (AOR=1.79, p<0.001) than among uninsured adults. Adults with major depressive episode-related severe impairment were more likely to use telehealth overall (AOR=1.55, p<0.001) and hybrid care. For substance use disorders, adults living in small metropolitan areas had lower telehealth use than those in large metropolitan areas (AOR=0.77, p<0.05). Telehealth use was also higher among those with moderate (AOR=2.72, p<0.001) or severe (AOR=10.04, p<0.001) substance use disorders than those with mild substance use disorders.
CONCLUSIONS: Telehealth and hybrid service use for major depressive episodes and substance use disorders remained largely stable in the postpandemic period. When integrated with in-person care, telehealth can help expand access to mental health and substance use treatment among U.S. adults.
METHODS: Pooled data from the 2022 and 2023 National Survey on Drug Use and Health (N=92,233) were analyzed to examine trends and patterns in overall telehealth use and hybrid service use among adults with past-year major depressive episodes and those with past-year substance use disorders. Bivariate analyses and survey-weighted multivariable logistic regression were conducted between December 2024 and May 2025.
RESULTS: Among adults with past-year major depressive episodes, telehealth use remained stable at around 44% from 2022 to 2023, whereas outpatient care remained the most common treatment modality and increased from 46.1% to 50.0% (OR=1.16, p<0.05). Among adults with past-year substance use disorders, telehealth use increased nonsignificantly from 5.4% in 2022 to 6.2% in 2023. For major depressive episodes, telehealth use was higher among females than among males (AOR=1.41, p<0.001) and among those with Medicaid (AOR=1.90, p<0.001) or private insurance (AOR=1.79, p<0.001) than among uninsured adults. Adults with major depressive episode-related severe impairment were more likely to use telehealth overall (AOR=1.55, p<0.001) and hybrid care. For substance use disorders, adults living in small metropolitan areas had lower telehealth use than those in large metropolitan areas (AOR=0.77, p<0.05). Telehealth use was also higher among those with moderate (AOR=2.72, p<0.001) or severe (AOR=10.04, p<0.001) substance use disorders than those with mild substance use disorders.
CONCLUSIONS: Telehealth and hybrid service use for major depressive episodes and substance use disorders remained largely stable in the postpandemic period. When integrated with in-person care, telehealth can help expand access to mental health and substance use treatment among U.S. adults.